AAWH Ascend Wellness Holdings, Inc.

AAWH financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1756390 Exchange: OTC SIC: 2833 (Medicinal Chemicals & Botanical Products) Latest filing: 10-Q filed Aug 12, 2026 Data checked: Oct 21, 2026
Showing 3 of 7 annual and 0 of 26 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
<br>Emerging growth company
Entity Type
Operating
Public Float
$54.77M (Jun 2025)
Industry (SIC)
2833 Medicinal Chemicals & Botanical Products
Incorporated
DE
Fiscal Year End
December (1231)
Phone
(646) 661-7600
EIN
830602006
Headquarters
ROCHELLE PARK, NJ, 07662
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: Ascend Wellness Holdings, Inc (2021–2022) · Ascend Wellness Holdings, LLC (2018–2021)

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
$488.33M
Net Income
-
Total Assets
$888.32M
Total Equity
$-85.09M
Total Debt
$318.83M
Free Cash Flow
$-6.95M
Ratios
Gross Margin
36.7%
Operating Margin
-2.2%
Current Ratio
1.66x
Debt / Equity
-3.75x
FCF / Assets
-0.8%

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

In fiscal 2025, Ascend Wellness Holdings, Inc. recorded revenue of $500.58M. Revenue of $500.58M sets the scale for evaluating how effectively sales translated into profit and cash during the year. The top line contracted 10.9% from $561.60M in fiscal 2024; this top-line contraction left the company with a smaller revenue base. The company reported diluted EPS of -$0.58, adding a shareholder-level measure to the absolute income figures considered below. Total assets stood at $907.93M, showing the scale of resources supporting revenue, earnings, liquidity, and financing. The revenue-to-assets relationship was 0.55x, showing the sales generated relative to the resources carried on the balance sheet.

Profitability

The first profit layer was $169.68M of gross profit, the amount available after reported direct revenue costs to absorb operating expenses. Gross profit represented 33.9% of revenue, showing how much of the top line remained after direct costs. Operations produced a $17.01M operating loss before non-operating and tax effects. The operating loss equaled 3.4% of revenue, showing the scale of the operating deficit relative to sales. Reported EBITDA totaled $24.03M, adding a pre-interest, tax, depreciation, and amortization perspective to the profitability profile. The pretax result was a loss of $66.81M, establishing the deficit before tax effects. Pretax margin was -13.3%, reflecting a pre-tax loss equal to 13.3% of revenue. The company recognized $51.38M of income tax for the period, completing the transition from pretax income to net income.

Liquidity and Capital Structure

Total assets were $907.93M, supported by $954.55M of liabilities and -$46.62M of shareholder equity. The company reported negative equity of -$46.62M, a capital deficit that reduces its ability to absorb losses through book equity. Current assets were $208.95M against $109.01M of current liabilities, framing the resources and obligations classified within the near-term balance-sheet horizon. At 1.92x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. Cash and equivalents totaled $85.68M, identifying the most liquid reported component available within the broader current-asset balance. The cash balance equaled 78.6% of current liabilities, showing how much near-term coverage came from cash alone. Total debt was $301.47M, establishing the amount of borrowing carried within the company’s capital structure. Debt represented 33.2% of total assets, placing borrowing in the context of the company’s full resource base. Book equity represented -5.1% of total assets, quantifying the balance-sheet share supported by shareholder capital. Liabilities represented 105.1% of total assets, quantifying the liability-funded share of the company’s resource base. Cash and equivalents equaled 9.4% of total assets, showing the liquid cash component within the company’s broader resource base. The asset base changed 0.8% from $900.43M in fiscal 2024, leaving current total assets higher year over year. Reported equity changed 164.9% from $71.80M in fiscal 2024, placing the current capital base lower year over year. Compared with $88.25M in fiscal 2024, the current cash balance moved 2.9% and finished lower.

Cash Flow and Earnings Quality

Cash flow from operations was $38.05M, a reported cash inflow that can be compared directly with net income and capital spending. Capital expenditures used $26.01M, identifying the reported investment outflow deducted from operating cash flow in the free-cash-flow calculation. Capital expenditures represented 68.3% of operating cash flow, leaving the remainder available as free cash flow. Free cash flow came to $12.04M, leaving a positive amount after capital expenditures. Relative to revenue, free cash flow equaled 2.4%, showing how much sales converted into cash after investment. The free-cash-flow-to-assets relationship was 1.3%, comparing post-investment cash with the balance-sheet asset base.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual financial statements for Ascend Wellness Holdings, Inc.
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $500.58M $561.60M $518.59M
Cost of Revenue $330.90M $377.39M $363.47M
Gross Profit $169.68M $184.21M $155.12M
OPERATING EXPENSES
SG&A Expense $169.69M $179.48M $158.74M
Operating Income $-17.01M $4.73M $-3.62M
NON-OPERATING INCOME / EXPENSE
Interest Expense $51.29M $45.26M $36.98M
Other Income/Expense $1.49M $707.00K $25.84M
Pretax Income $-66.82M $-39.82M $-14.76M
Income Tax $51.38M $45.17M $33.45M
PER SHARE & SUPPLEMENTAL
Diluted EPS $-0.58 $-0.40 $-0.24
Diluted Shares 203.48M 212.43M 199.15M
EBITDA $24.03M $39.71M $25.92M
Depreciation & Amortization $41.05M $34.98M $29.53M
Balance Sheet
ASSETS
Cash & Equivalents $85.68M $88.25M $72.51M
Accounts Receivable $27.02M $36.54M $28.30M
Inventory $84.71M $89.55M $95.29M
Other Current Assets $11.19M $10.93M $19.64M
Current Assets $208.95M $229.38M $228.86M
PP&E (Net) $382.40M $260.46M $268.08M
Goodwill $58.45M $49.60M $47.54M
Intangible Assets $196.07M $205.50M $221.45M
Other Noncurrent Assets $14.99M $16.43M $23.06M
Noncurrent Assets $698.98M $671.06M $690.69M
Total Assets $907.93M $900.43M $919.55M
LIABILITIES
Accounts Payable $20.91M $26.41M $34.69M
Short-term Debt $10.37M $72.69M -
Other Current Liabilities $7.07M $5.06M $6.77M
Current Liabilities $109.01M $144.54M $92.69M
Long-term Debt $291.10M $214.42M -
Other Noncurrent Liabilities $210.46M $158.89M $89.60M
Noncurrent Liabilities $845.54M $684.09M $683.99M
Total Liabilities $954.55M $828.63M $776.68M
EQUITY
Additional Paid-in Capital $470.91M $471.13M $458.03M
Retained Earnings $-518.55M $-400.36M $-315.36M
Total Equity $-46.62M $71.80M $142.87M
Total Liabilities & Equity $907.93M $900.43M $919.55M
SUPPLEMENTAL
Total Debt $301.47M $287.11M -
Shares Outstanding 202.22M 205.03M 206.88M
Check: A − (L + E + Temp. Equity) - - -
Cash Flow Statement
Cash from Operations $38.05M $73.29M $75.33M
Capital Expenditures $26.01M $22.53M $24.25M
Cash from Investing $-45.74M $-37.20M $-59.89M
Cash from Financing $5.11M $-20.35M $-17.08M
Free Cash Flow $12.04M $50.76M $51.09M
Beginning Cash (CFS) $88.25M $72.51M $74.15M
Net Change in Cash $-2.58M $15.75M $-1.64M
Effect of FX on Cash - - -
Calculated Ending Cash $85.68M $88.25M $72.51M
Cash per BS $85.68M $88.25M $72.51M
Cash scope difference (CFS − BS) - - -
Cash per CFS $85.68M $88.25M $72.51M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is Ascend Wellness Holdings, Inc.'s annual revenue?

Ascend Wellness Holdings, Inc. reported $488.33M in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

What is Ascend Wellness Holdings, Inc.'s debt level?

Ascend Wellness Holdings, Inc. carries $318.83M in total debt as of trailing twelve months. Total shareholders' equity stands at $-85.09M.

Does Ascend Wellness Holdings, Inc. generate free cash flow?

No. Free cash flow was $-6.95M for trailing twelve months. Operating cash flow was $17.35M.